Dr. Hirva Mamdani, MD
Claim this profileKarmanos Cancer Institute
Expert in Non-Small Cell Lung Cancer
Studies Lung Cancer
20 reported clinical trials
29 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
ALK positive
2Lung Cancer
Stage IV
Stage III
ALK positive
Affiliated Hospitals
Clinical Trials Hirva Mamdani, MD is currently running
LYL797
for Breast and Lung Cancer
This trial is testing a new treatment called LYL797, which uses modified immune cells to target and kill hard-to-treat breast and lung cancer cells. The study aims to find a safe dose and see how well it works in patients whose cancers have not responded to other treatments.
Recruiting1 award Phase 17 criteria
Chiauranib
for Advanced Cancers
This trial is testing a new drug called chiauranib for patients with advanced cancers that don't respond to standard treatments. It aims to block the signals that cancer cells need to grow. The focus is on patients with small cell lung cancer that has worsened after previous treatments.
Recruiting1 award Phase 1 & 28 criteria
More about Hirva Mamdani, MD
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Hirva Mamdani, MD has experience with
- Pembrolizumab
- Nivolumab
- GT103
- Atezolizumab
- SGN-EGFRd2
- Ipilimumab
Breakdown of trials Hirva Mamdani, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hirva Mamdani, MD specialize in?
Hirva Mamdani, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Hirva Mamdani, MD currently recruiting for clinical trials?
Yes, Hirva Mamdani, MD is currently recruiting for 10 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Hirva Mamdani, MD has studied deeply?
Yes, Hirva Mamdani, MD has studied treatments such as Pembrolizumab, Nivolumab, GT103.
What is the best way to schedule an appointment with Hirva Mamdani, MD?
Apply for one of the trials that Hirva Mamdani, MD is conducting.
What is the office address of Hirva Mamdani, MD?
The office of Hirva Mamdani, MD is located at: Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.